Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 22.86
-2.54 (-10.00%)
Oct 2, 2026, 5:35 PM CET
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €1.29 billion as of October 2, 2026. Its market cap has increased by 65.03% in one year.
Market Cap
1.29B
Enterprise Value
1.29B
Revenue
11.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
€22.86
ChartMarket Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 1.29B, an increase of 1,851.74%. That is a compound annual growth rate of 23.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.16B | 23.12% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.34B |
| MedinCell | 832.43M |
| Inventiva | 719.47M |
| DBV Technologies | 579.99M |
| Valneva SE | 495.17M |
| Genfit | 472.23M |
| Valerio Therapeutics Société anonyme | 264.21M |
| Transgene | 195.55M |